Home/ Supplements/ Omega 3/ Algal-900 DHA

Algal-900 DHA

product on market Softgel Capsule CVS Pharmacy Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 33% of ingredients have research evidence
A Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

Algal docosahexaenoic acid (DHA) is an omega-3 fatty acid that supports cognitive function and cardiovascular health. There is strong evidence supporting the role of DHA in maintaining brain health and reducing inflammation. The overall ingredient profile is considered safe for general consumption.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for Algal-900 DHA
Open Full PDF View on NIH DSLD →
Details

Label Data

1 Softgel(s)
Serving Size
Fat/Fatty Acid
Product Type
33%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Calories
10 {Calories}
Total Fat
1 g (2% DV)
Market median: 750.0mg (447 products) 393 studies (A:18, B:204)

Other Ingredients

Gelatin Capsule high Oleic Sunflower Oil Sunflower Lecithin Rosemary extract Tocopherols Ascorbyl Palmitate
Claims

Label Claims — Verification

Unverified All Other
Info

Product Information

Directions for Use

DIRECTIONS: As a dietary supplement, for heart & eye benefits - take one softgel daily. For memory benefits - take three softgels daily. Take with food.

Warnings & Precautions

Consult your doctor before taking any supplement.

Formulation Notes

ALGAE BASED, FISH FREE OMEGA-3

FISH FREE, ALGAE-SOURCED DHA

For adults only.

Additional Information

- Supports eye & heart health

CLINICALLY PROVEN MEMORY IMPROVEMENT

NEW

life's DHA(TM) HEALTHY BRAIN, EYES, HEART

MADE IN THE USA

- The only DHA form and dosage clinically proven to improve memory - Supports heart health - Supports eye health

Metadata

Product Details

DSLD Entry Date2012-10-25
Product TypeFat/Fatty Acid
FormSoftgel Capsule
DSLD ID12944
Data Updated2026-04-11
Research

Research Evidence

495
Research Sources
56
Avg Quality
222
Meta Analysis
104
Clinical Trial
72
Rct
69
Systematic Review
11
Guideline
5
Cochrane Review
5
Regulatory Source
3
Narrative Review
1
Openfda Safety
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2020 PubMed DOI
A Omega-3 fatty acid addition during pregnancy
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Omega-3 fatty acids for depression in adults
Systematic Review The Cochrane database of systematic reviews 2021 PubMed DOI
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Non-immunosuppressive treatment for IgA nephropathy
Meta Analysis The Cochrane database of systematic reviews 2024 PubMed DOI
A Omega-3 fatty acid supplementation for depression in children and adolescents
Meta Analysis The Cochrane database of systematic reviews 2024 PubMed DOI
A Interventions for fatigue and weight loss in adults with advanced progressive illness
Meta Analysis The Cochrane database of systematic reviews 2012 PubMed DOI
A Motor control exercise for chronic non-specific low-back pain
Meta Analysis The Cochrane database of systematic reviews 2016 PubMed DOI
A Polyunsaturated fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
View all evidence for Omega 3 →
Compare

Similar Products

View all Omega 3 products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.